Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Bajaj HS, Bergenstal RM, Christoffersen A, et al. Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in type 2 diabetes inadequately controlled on daily basal insulin: a phase 2 randomized controlled trial. Diabetes Care 2021; 4(7):1586-1594
2. Best JH, Boye KS, Rubin RR, et al. Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diabet Med 2009;26(7):722-728
3. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungs-Leitlinie Typ-2-Diabetes - Teilpublikation der Langfassung, 2. Auflage. Version 1. 2021. http://leitlinien.de/diabetes (zugegriffen am 23.08.2022)
4. Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ 2011;37(1):111-123
5. International Diabetes Federation. IDF Diabetes Atlas 10th edition. 2021. http://www.diabetesatlas.org/ (zugegriffen am 18.07.2021)